Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stephanie J. Lee, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Cancer Institute at Oregon Health and Science University
Portland, Oregon, United States
- Baylor University Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2001
- Primary completion
- 30 Nov 2003
- Completion
- 30 Nov 2004
- Last update posted
- 23 Jan 2017
- Registered enrollment
- 105
- Registry id
- NCT00053976
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.